PATENT CLAIM ANALYSIS

Application Number: 16117653
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "182000"]

Abstract:
Compositions and methods for treating addiction in a subject are disclosed. In particular, compositions and methods for treating addiction to a dopaminergic psychostimulant are disclosed. In some embodiments, addiction is treated by agonizing bile acid receptors in the subject. For example, in some embodiments, the method comprises administering to the subject a therapeutically effective amount of a composition comprising a therapeutically effective amount of a bile acid receptor agonist. In some embodiments, the method comprises surgically diverting bile acids in the subject in a manner suitable to increase circulating bile acids in the subject.

Claim (Index 11):
The composition of  claim 9 , wherein the bile acid receptor agonist is selected from the group consisting of cholic acid (CA), lithocholic (LCA), taurolithocholic acid (TLCA), deoxycholic acid (DCA), chenodeoxycholic acid (CDCA), ursodeoxycholic acid (UDCA), linolenic acid, oleanolic acid, betulinic acid, or any combination thereof.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 96.0
- Lexical Diversity: 2.12245
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15218976', '12622123', '13313689', '13871492', '15178138']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7834671663252369
- 35 USC 102 Novelty (BERT): 0.5802581789598927
- Combined Prediction Score: 0.7631462675887025
- Mean Citation Score: 259.273774
- Max Citation Score: 544.6472
- Similarity Product: 376.90769625577934

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test